Medtronic Statistics
Total Valuation
Medtronic has a market cap or net worth of $124.84 billion. The enterprise value is $143.63 billion.
| Market Cap | 124.84B |
| Enterprise Value | 143.63B |
Important Dates
The last earnings date was Tuesday, February 17, 2026, before market open.
| Earnings Date | Feb 17, 2026 |
| Ex-Dividend Date | Dec 26, 2025 |
Share Statistics
Medtronic has 1.28 billion shares outstanding. The number of shares has decreased by -0.82% in one year.
| Current Share Class | 1.28B |
| Shares Outstanding | 1.28B |
| Shares Change (YoY) | -0.82% |
| Shares Change (QoQ) | +0.12% |
| Owned by Insiders (%) | 0.05% |
| Owned by Institutions (%) | 86.97% |
| Float | 1.28B |
Valuation Ratios
The trailing PE ratio is 27.16 and the forward PE ratio is 16.33. Medtronic's PEG ratio is 2.99.
| PE Ratio | 27.16 |
| Forward PE | 16.33 |
| PS Ratio | 3.50 |
| Forward PS | 3.25 |
| PB Ratio | 2.53 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 22.94 |
| P/OCF Ratio | 17.03 |
| PEG Ratio | 2.99 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 15.22, with an EV/FCF ratio of 26.55.
| EV / Earnings | 31.14 |
| EV / Sales | 4.05 |
| EV / EBITDA | 15.22 |
| EV / EBIT | 21.66 |
| EV / FCF | 26.55 |
Financial Position
The company has a current ratio of 2.54, with a Debt / Equity ratio of 0.57.
| Current Ratio | 2.54 |
| Quick Ratio | 1.55 |
| Debt / Equity | 0.57 |
| Debt / EBITDA | 2.88 |
| Debt / FCF | 5.19 |
| Interest Coverage | 9.30 |
Financial Efficiency
Return on equity (ROE) is 9.39% and return on invested capital (ROIC) is 7.97%.
| Return on Equity (ROE) | 9.39% |
| Return on Assets (ROA) | 4.57% |
| Return on Invested Capital (ROIC) | 7.97% |
| Return on Capital Employed (ROCE) | 8.09% |
| Weighted Average Cost of Capital (WACC) | 7.08% |
| Revenue Per Employee | $373,516 |
| Profits Per Employee | $48,558 |
| Employee Count | 95,000 |
| Asset Turnover | 0.39 |
| Inventory Turnover | 2.07 |
Taxes
In the past 12 months, Medtronic has paid $923.00 million in taxes.
| Income Tax | 923.00M |
| Effective Tax Rate | 16.59% |
Stock Price Statistics
The stock price has increased by +7.25% in the last 52 weeks. The beta is 0.72, so Medtronic's price volatility has been lower than the market average.
| Beta (5Y) | 0.72 |
| 52-Week Price Change | +7.25% |
| 50-Day Moving Average | 99.02 |
| 200-Day Moving Average | 93.94 |
| Relative Strength Index (RSI) | 41.97 |
| Average Volume (20 Days) | 9,063,051 |
Short Selling Information
The latest short interest is 19.72 million, so 1.54% of the outstanding shares have been sold short.
| Short Interest | 19.72M |
| Short Previous Month | 14.40M |
| Short % of Shares Out | 1.54% |
| Short % of Float | 1.54% |
| Short Ratio (days to cover) | 2.60 |
Income Statement
In the last 12 months, Medtronic had revenue of $35.48 billion and earned $4.61 billion in profits. Earnings per share was $3.58.
| Revenue | 35.48B |
| Gross Profit | 23.12B |
| Operating Income | 6.63B |
| Pretax Income | 5.56B |
| Net Income | 4.61B |
| EBITDA | 9.44B |
| EBIT | 6.63B |
| Earnings Per Share (EPS) | $3.58 |
Balance Sheet
The company has $8.38 billion in cash and $28.07 billion in debt, with a net cash position of -$19.54 billion or -$15.22 per share.
| Cash & Cash Equivalents | 8.38B |
| Total Debt | 28.07B |
| Net Cash | -19.54B |
| Net Cash Per Share | -$15.22 |
| Equity (Book Value) | 49.20B |
| Book Value Per Share | 38.17 |
| Working Capital | 14.58B |
Cash Flow
In the last 12 months, operating cash flow was $7.29 billion and capital expenditures -$1.88 billion, giving a free cash flow of $5.41 billion.
| Operating Cash Flow | 7.29B |
| Capital Expenditures | -1.88B |
| Free Cash Flow | 5.41B |
| FCF Per Share | $4.21 |
Margins
Gross margin is 65.16%, with operating and profit margins of 18.68% and 13.00%.
| Gross Margin | 65.16% |
| Operating Margin | 18.68% |
| Pretax Margin | 15.67% |
| Profit Margin | 13.00% |
| EBITDA Margin | 26.60% |
| EBIT Margin | 18.68% |
| FCF Margin | 15.25% |
Dividends & Yields
This stock pays an annual dividend of $2.84, which amounts to a dividend yield of 2.92%.
| Dividend Per Share | $2.84 |
| Dividend Yield | 2.92% |
| Dividend Growth (YoY) | 1.43% |
| Years of Dividend Growth | 50 |
| Payout Ratio | 79.05% |
| Buyback Yield | 0.82% |
| Shareholder Yield | 3.75% |
| Earnings Yield | 3.72% |
| FCF Yield | 4.36% |
Analyst Forecast
The average price target for Medtronic is $109.82, which is 12.94% higher than the current price. The consensus rating is "Buy".
| Price Target | $109.82 |
| Price Target Difference | 12.94% |
| Analyst Consensus | Buy |
| Analyst Count | 19 |
| Revenue Growth Forecast (5Y) | 5.98% |
| EPS Growth Forecast (5Y) | 15.39% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 27, 1999. It was a forward split with a ratio of 2:1.
| Last Split Date | Sep 27, 1999 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
Medtronic has an Altman Z-Score of 2.98 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.98 |
| Piotroski F-Score | 6 |